Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN103553932A details a safer, scalable route for Memantine HCl using controlled exotherms and green solvents, offering cost-effective API intermediate manufacturing.
This patent details a novel purification method for Losartan achieving 99.5% purity. It offers significant cost reduction and supply chain reliability for pharmaceutical manufacturers seeking high-quality intermediates.
Patent CN114574454B details enzymatic synthesis for Tenofovir intermediates. Discover cost-effective, scalable biocatalytic solutions for pharmaceutical manufacturing.
Novel synthesis route for gut-brain axis metabolite ensuring high yield and mild conditions. Reliable supply chain partner for pharmaceutical research and development teams seeking high-purity intermediates.
Patent CN104152505A details enzymatic production of 4-HIL. Offers high yield and scalable supply chain solutions for diabetes treatment intermediates.
Patent CN112063610B details TPL mutants achieving 146g/L L-DOPA. Offers superior catalytic efficiency for pharmaceutical manufacturing supply chains.
Patent CN102701946B details a novel centrifugal inclusion method for high-purity phenylsuccinic acid separation, offering scalable chiral resolution solutions.
Novel patent CN107602589A details a scalable BMS-986120 synthesis using phloroglucinol, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN109020877A details a Pd-catalyzed C-H activation route for alkyl-modified arylpyridines, offering high atom economy and mild conditions for reliable pharmaceutical intermediate supply chains.
Patent CN113818033A reveals a metal-free electrochemical route for 2-substituted benzoxazoles, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN1312118C enables green carnitine production. Reduces costs and improves supply chain reliability for pharmaceutical intermediates globally.
Patent CN104830943A reveals enzymatic resolution for high-purity eldecalcitol intermediate, offering cost reduction and scalable supply chain solutions for pharmaceutical manufacturers.
Patent CN103965160A details a novel synthesis for clopidogrel intermediates. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable methods.
Patent CN107827816B reveals a metal-free graphene oxide catalytic method for high-yield formamide derivative synthesis, offering significant cost reduction and supply chain stability.
Novel process for TH-302 intermediates via CN105814032A. Enhances yield and safety for API manufacturing supply chains.
Patent CN107382644A reveals a Pd-catalyzed route for high-purity chiral tertiary alcohols. Discover cost reduction in chiral drug manufacturing and supply advantages.
Patent CN102964401A details a novel hydrogenation method to eliminate dehydro-clindamycin phosphate impurities, ensuring superior API quality and scalable manufacturing.
Patent CN1487941A details a safer, scalable route for temozolomide production, offering significant cost reduction in API manufacturing and enhanced supply chain stability for global buyers.
Discover the patented medium-pressure chromatography method for producing high-purity Orlistat. Achieve >99.5% purity with scalable, cost-effective manufacturing processes.
Patent CN104844667B reveals high yield hydrolysis method. Reduces waste and cost for pharmaceutical intermediates. Reliable supply chain partner for scale-up.